Atlas Trials

Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)

Clinical trial NCT06553768 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06553768
Sponsor
Mirum Pharmaceuticals, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
Start date
2024-10-14
Primary completion
2026-10-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.